BRITTANY DAVIDSON: Open Payments
NPI 1043754815 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 112 payments from 16 companies in 2025. Trend: 2023 $1,652 · 2024 $2,413 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $495 |
| Ardelyx, Inc. | 16 | $211 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $184 |
| Janssen Biotech, Inc. | 13 | $158 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Madrigal Pharmaceuticals | 3 | $73 |
| Aimmune Therapeutics, Inc. | 3 | $54 |
| Intercept Pharmaceuticals, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $37 |
| GENZYME CORPORATION | 1 | $34 |
Products named: RINVOQ, IBSRELA, XIFAXAN, TREMFYA, CREON, VOQUEZNA, REZDIFFRA, SKYRIZI.
Industry payments across KY — which companies pay providers there.
